Correlation Between Viracta Therapeutics and Tempus AI,

Can any of the company-specific risk be diversified away by investing in both Viracta Therapeutics and Tempus AI, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viracta Therapeutics and Tempus AI, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viracta Therapeutics and Tempus AI, Class, you can compare the effects of market volatilities on Viracta Therapeutics and Tempus AI, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viracta Therapeutics with a short position of Tempus AI,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viracta Therapeutics and Tempus AI,.

Diversification Opportunities for Viracta Therapeutics and Tempus AI,

-0.44

Correlation Coefficient

Viracta Therapeutics  Tempus AI,

Very good diversification

The 3 months correlation between Viracta and Tempus is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Viracta Therapeutics and Tempus AI, Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempus AI, Class and Viracta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viracta Therapeutics are associated (or correlated) with Tempus AI,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempus AI, Class has no effect on the direction of Viracta Therapeutics i.e., Viracta Therapeutics and Tempus AI, go up and down completely randomly.

Pair Corralation between Viracta Therapeutics and Tempus AI,

Given the investment horizon of 90 days Viracta Therapeutics is expected to under-perform the Tempus AI,. But the stock apears to be less risky and, when comparing its historical volatility, Viracta Therapeutics is 1.1 times less risky than Tempus AI,. The stock trades about -0.02 of its potential returns per unit of risk. The Tempus AI, Class is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  4,025  in Tempus AI, Class on October 9, 2024 and sell it today you would lose (137.00) from holding Tempus AI, Class or give up 3.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	57.49%
Values	Daily Returns

Viracta Therapeutics  vs.  Tempus AI, Class

Viracta Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Viracta Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Viracta Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Tempus AI, Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tempus AI, Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Tempus AI, is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Viracta Therapeutics and Tempus AI,

The main advantage of trading using opposite Viracta Therapeutics and Tempus AI, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viracta Therapeutics position performs unexpectedly, Tempus AI, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempus AI, will offset losses from the drop in Tempus AI,'s long position.

The idea behind Viracta Therapeutics and Tempus AI, Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.